You need JavaScript to view this

Urinary excretion and patterns of protein binding of iodipamide (Biligrafin forte). A comparison of the infusion technique with the single bolus injection in intravenous cholangiography

Abstract

It has been suggested that the bile ducts are seen better during intravenous cholangiography when the contrast medium is given by infusion rather than by injection in a single bolus. As an explanation, it has been proposed that a greater amount of contrast medium is bound to plasma proteins after infusion, resulting in a smaller quantity of contrast medium being excreted in the urine, so leaving a larger total for excretion by the liver. In this study, the urinary excretion of /sup 125/I labelled iodipamide methylglucamine (50% w/v Biligrafin forte) has been measured in 42 patients. The patients were divided into two groups. One group received a slow infusion of radioactive iodipamide over 45 minutes and the other an intravenous injection over five minutes. When a relatively high dose (0.6 mg/kg body weight) was used, no difference in urinary excretion was noted between these two groups; but with a lower dose (0.2 mg/kg body weight), slow infusion resulted in a reduced urinary excretion; however the total difference in contrast lost in the urine was too small to affect biliary concentration. The patterns of protein binding of iodipamide have been examined in 12 of these patients. The results showed that at  More>>
Authors:
Husband, J; Saxton, H M [1] 
  1. Guy's Hospital, London (UK)
Publication Date:
Jan 01, 1978
Product Type:
Journal Article
Reference Number:
AIX-09-365432; EDB-78-091845
Resource Relation:
Journal Name: Br. J. Radiol.; (United Kingdom); Journal Volume: 51:601
Subject:
59 BASIC BIOLOGICAL SCIENCES; 62 RADIOLOGY AND NUCLEAR MEDICINE; BILIARY TRACT; BIOMEDICAL RADIOGRAPHY; CONTRAST MEDIA; ORGANIC IODINE COMPOUNDS; BIOLOGICAL LOCALIZATION; RENAL CLEARANCE; PBI; BLOOD SERUM; BLOOD VESSELS; COMPARATIVE EVALUATIONS; DOSE-RESPONSE RELATIONSHIPS; INTRAVENOUS INJECTION; IODINE 125; LIVER; PATIENTS; RADIONUCLIDE KINETICS; RESPONSE MODIFYING FACTORS; BETA DECAY RADIOISOTOPES; BODY; CARDIOVASCULAR SYSTEM; CLEARANCE; CPB; DAYS LIVING RADIOISOTOPES; DIAGNOSTIC TECHNIQUES; DIGESTIVE SYSTEM; ELECTRON CAPTURE RADIOISOTOPES; EXCRETION; GLANDS; INJECTION; INTAKE; INTERMEDIATE MASS NUCLEI; IODINE ISOTOPES; ISOTOPES; MEDICINE; NUCLEAR MEDICINE; NUCLEI; ODD-EVEN NUCLEI; ORGANIC COMPOUNDS; ORGANIC HALOGEN COMPOUNDS; ORGANS; PROTEINS; RADIOISOTOPES; RADIOLOGY; 550501* - Metabolism- Tracer Techniques; 550600 - Medicine
OSTI ID:
6782545
Country of Origin:
United Kingdom
Language:
English
Other Identifying Numbers:
Journal ID: CODEN: BJRAA
Submitting Site:
INIS
Size:
Pages: 11-16
Announcement Date:
Mar 01, 1978

Citation Formats

Husband, J, and Saxton, H M. Urinary excretion and patterns of protein binding of iodipamide (Biligrafin forte). A comparison of the infusion technique with the single bolus injection in intravenous cholangiography. United Kingdom: N. p., 1978. Web.
Husband, J, & Saxton, H M. Urinary excretion and patterns of protein binding of iodipamide (Biligrafin forte). A comparison of the infusion technique with the single bolus injection in intravenous cholangiography. United Kingdom.
Husband, J, and Saxton, H M. 1978. "Urinary excretion and patterns of protein binding of iodipamide (Biligrafin forte). A comparison of the infusion technique with the single bolus injection in intravenous cholangiography." United Kingdom.
@misc{etde_6782545,
title = {Urinary excretion and patterns of protein binding of iodipamide (Biligrafin forte). A comparison of the infusion technique with the single bolus injection in intravenous cholangiography}
author = {Husband, J, and Saxton, H M}
abstractNote = {It has been suggested that the bile ducts are seen better during intravenous cholangiography when the contrast medium is given by infusion rather than by injection in a single bolus. As an explanation, it has been proposed that a greater amount of contrast medium is bound to plasma proteins after infusion, resulting in a smaller quantity of contrast medium being excreted in the urine, so leaving a larger total for excretion by the liver. In this study, the urinary excretion of /sup 125/I labelled iodipamide methylglucamine (50% w/v Biligrafin forte) has been measured in 42 patients. The patients were divided into two groups. One group received a slow infusion of radioactive iodipamide over 45 minutes and the other an intravenous injection over five minutes. When a relatively high dose (0.6 mg/kg body weight) was used, no difference in urinary excretion was noted between these two groups; but with a lower dose (0.2 mg/kg body weight), slow infusion resulted in a reduced urinary excretion; however the total difference in contrast lost in the urine was too small to affect biliary concentration. The patterns of protein binding of iodipamide have been examined in 12 of these patients. The results showed that at the low dose a higher percentage of radioactive iodipamide was bound to protein in patients given contrast by infusion. There was clear evidence that the contrast binding capacity of plasma was limited so that with higher doses, much contrast remained unbound. At any given dose level, there was inverse correlation between the proportion of contrast bound to protein and the urinary excretion. The factors affecting contrast binding in individual subjects were not clear.}
journal = []
volume = {51:601}
journal type = {AC}
place = {United Kingdom}
year = {1978}
month = {Jan}
}